DOI:
10.1055/s-00029025
Journal of Pediatric Epilepsy
LinksClose Window
References
Arzimanoglou A, Ferreira JA, Satlin A. et al.
Safety and pharmacokinetic profile of rufinamide in pediatric patients aged less than 4 years with Lennox-Gastaut syndrome: an interim analysis from a multicenter, randomized, active-controlled, open-label study.
Eur J Paediatr Neurol 2016;
20 (03) 393-402
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.